v3.26.1
Nature of Operations - Additional Information (Details)
3 Months Ended 12 Months Ended
Sep. 23, 2025
USD ($)
shares
Sep. 22, 2025
USD ($)
shares
Aug. 20, 2025
USD ($)
shares
Jul. 22, 2025
shares
Jun. 12, 2025
shares
Mar. 31, 2026
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
shares
Organization and Business Operation [Line Items]                
Common stock, per value (in Dollars per share) | $ / shares           $ 0.0001   $ 0.0001
Common stock, shares issued           230,209,142   230,209,142
Warrants outstanding           7,432,122    
Exercise price, per share (in Dollars per share) | $ / shares           $ 11.5    
Warrants expiration date           Sep. 30, 2027    
Warrants exercised on cashless basis               1,327,878
Issuance of common stock upon cashless exercise of warrants               468,164
Warrants exercisable for shares of common stock           7,432,122    
Cash and cash equivalents | $           $ 103,000   $ 20,000
Accumulated deficit | $           (280,376,000)   $ (275,800,000)
Operating losses | $           4,576,000 $ 665,000  
Cash flows from operations | $           $ (2,670,000) $ (399,000)  
Shares of common stock (in Shares)           300,000    
Sponsor [Member]                
Organization and Business Operation [Line Items]                
Common stock held shares   2,072,500            
Debt conversion original debt amount | $   $ 100,000            
Securities Purchase Agreement (PIPE SPA)                
Organization and Business Operation [Line Items]                
Common stock, shares issued           0    
Consulting Services Agreement with JW Investment Management Company Limited [Member]                
Organization and Business Operation [Line Items]                
Percentage of cash financing service fee         7.00% 7.00%    
Scilex Holding Company [Member]                
Organization and Business Operation [Line Items]                
Common stock held shares   500,000            
Scilex Holding Company [Member] | Legacy Semnur Stock Options [Member]                
Organization and Business Operation [Line Items]                
Conversion of shares converted           400,000,000    
Scilex Holding Company [Member] | Stock Option [Member]                
Organization and Business Operation [Line Items]                
Conversion of shares issued           50,000,000    
Scilex Holding Company [Member] | Debt Exchange Agreement [Member]                
Organization and Business Operation [Line Items]                
Debt conversion original debt amount | $   $ 54,200,000            
Denali Capital Global Investments LLC [Member]                
Organization and Business Operation [Line Items]                
Business combination, prepaid expenses | $   12,000            
Business combination, accouts payable | $   4,400,000            
Business combination, related party liabilities | $   3,900,000            
Business combination, notes payable | $   $ 4,600,000            
Merger Agreement [Member]                
Organization and Business Operation [Line Items]                
Common stock exchange ratio           1.25    
Business combination shares exchanged   229,740,978            
Legacy Semnur Series A Preferred Stock [Member] | Scilex Holding Company [Member] | Debt Exchange Agreement [Member]                
Organization and Business Operation [Line Items]                
Debt conversion, converted instrument, shares issued   5,423,606            
Class B Ordinary Shares [Member]                
Organization and Business Operation [Line Items]                
Sale of stock price per share (in Dollars per share) | $ / shares           $ 0.0001    
Per public share (in Dollars per share) | $ / shares           $ 0.0001    
Agreed to purchase (in Shares)           500,000    
Aggregate consideration to purchase | $           $ 2,000,000    
Series A Preferred Stock [Member] | Scilex Holding Company [Member] | Debt Exchange Agreement [Member]                
Organization and Business Operation [Line Items]                
Debt conversion, converted instrument, shares issued   5,423,606            
Legacy Semnur Common Stock [Member] | Scilex Holding Company [Member]                
Organization and Business Operation [Line Items]                
Conversion of shares converted           160,000,000    
Common Stock [Member] | Sponsor [Member]                
Organization and Business Operation [Line Items]                
Conversion of shares converted   2,072,500            
Debt conversion, converted instrument, shares issued   12,488            
Common Stock [Member] | Securities Purchase Agreement (PIPE SPA)                
Organization and Business Operation [Line Items]                
Sponsor transferred (in Shares)     1,250,000          
Sale of stock per transaction | $     $ 16,000          
Total consideration | $     $ 20,000,000          
Common Stock [Member] | Bitcoin Securities Purchase Agreement [Member]                
Organization and Business Operation [Line Items]                
Sponsor transferred (in Shares) 6,250,000              
Sale of stock per transaction | $ $ 16,000              
Total consideration | $ $ 100,000,000              
Common Stock [Member] | Consulting Services Agreement with JW Investment Management Company Limited [Member]                
Organization and Business Operation [Line Items]                
Sponsor transferred (in Shares)       8,000,000 10,000,000 10,000,000    
Common Stock [Member] | Scilex Holding Company [Member]                
Organization and Business Operation [Line Items]                
Conversion of shares converted   500,000            
Conversion of shares issued           200,000,000    
Common Stock [Member] | Scilex Holding Company [Member] | Debt Exchange Agreement [Member]                
Organization and Business Operation [Line Items]                
Debt conversion, converted instrument, shares issued   542,361            
Warrant [Member]                
Organization and Business Operation [Line Items]                
Exercise price, per share (in Dollars per share) | $ / shares           $ 0.01    
Per public share (in Dollars per share) | $ / shares           $ 16.5    
Redemption of unexpired warrants, description           The Company may redeem any unexpired Warrants prior to their exercise at a price of $0.01 per Warrant, provided that the closing price of Common Stock equals or exceeds $16.50 per share (as adjusted for share subdivisions, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) on each of 20 trading days within any 30-trading-day period commencing after the Warrants became exercisable and ending on the third trading day prior to the date on which notice of redemption is given. If and when the Warrants become redeemable, the Company may exercise its redemption right even if they are unable to register or qualify the underlying securities for sale under all applicable state securities laws. In addition, the Company may redeem the Warrants at any time after they become exercisable and prior to their expiration for a number of shares of Common Stock determined based on the fair market value of Common Stock.    
Consultants [Member] | Merger Agreement [Member]                
Organization and Business Operation [Line Items]                
Business combination shares exchanged   26,500,000            
Underwriters [Member] | Merger Agreement [Member]                
Organization and Business Operation [Line Items]                
Business combination shares exchanged   100,000